<table border="1" id="inv-e957d915-a6d1-4066-bbd4-24b4db611206" width="458" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="inv-c675be66-f7d4-4888-9245-50493f6f3c94">TABLE 1: SUMMARY OF EFFECTIVENESS DATA IN PLACEBO-CONTROLLED TRIALS</caption>
<col width="31.7%"></col>
<col width="7.4%"></col>
<col width="14.8%"></col>
<col width="12.9%"></col>
<col width="5.5%"></col>
<col width="14.8%"></col>
<col width="12.9%"></col>
<tbody>
<tr id="id_0afd15da-cbe6-4d14-9e0a-8cdda0711723">
<td align="left" rowspan="2" stylecode="Botrule Toprule Rrule Lrule" valign="middle">
<content stylecode="bold"> </content>
</td>
<td align="center" colspan="3" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">SYMPTOM SCORE</content>
<footnote id="id-a4e7fcae-6560-4d63-96f1-8356d0d670be">AUA questionnaire (range 0 to 30) in <content stylecode="bold">STUDIES 1</content> and <content stylecode="bold">3</content>. Modified Boyarsky Questionnaire (range 7 to 39) in <content stylecode="bold">STUDY 2</content>.</footnote>
</td>
<td align="center" colspan="3" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MAXIMUM FLOW RATE (mL/sec)</content>
<content stylecode="bold"> </content>
</td>
</tr>
<tr id="id_52f89a79-8ce2-45ea-b603-61f807527983">
<td align="center" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">
<content stylecode="underline">N</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN BASELINE</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN</content>
<footnote id="id-e33886f3-f5c3-40d6-9bde-9db92b2605cc">Change is to endpoint.</footnote>
<content stylecode="bold">CHANGE</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">
<content stylecode="underline">N</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN BASELINE</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN</content>
<footnote id="id-965d3d56-3b20-4057-b75f-8f6ddd967319">Change is to fixed-dose efficacy phase, 22 to 26 hours post-dose for <content stylecode="bold">STUDIES 1</content> and <content stylecode="bold">3</content> and 2 to 6 hours post-dose for <content stylecode="bold">STUDY 2</content>.</footnote>
<content stylecode="bold">CHANGE</content>
</td>
</tr>
<tr id="id_a97e9ae4-8a81-4c84-93c2-5875f6bebdab">
<td align="left" colspan="7" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">STUDY 1 (Titration to maximum dose of 8 mg)</content>
<footnote id="id-d8bff59f-9cf3-4e70-b6b4-1ee5c2794233">36 patients received a dose of 8 mg doxazosin mesylate.</footnote>
</td>
</tr>
<tr id="id_70f55f44-662e-4be8-a4f1-b0c83d62507f">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Placebo</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">47</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">15.6</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-2.3</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">41</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.7</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+0.7</td>
</tr>
<tr id="id_377a4201-3aee-4a61-86ec-b161fcbd2f72">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">49</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">14.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-4.9<footnote id="id-eeda9e0c-6df2-45ba-aeb9-76a78be55437">p &lt; 0.01 compared to placebo mean change.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">41</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.8</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+2.9<footnoteref idref="id-eeda9e0c-6df2-45ba-aeb9-76a78be55437"></footnoteref>
</td>
</tr>
<tr id="id_2beba191-b989-46c5-9c6a-1f3b76fbc722">
<td align="left" colspan="7" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">STUDY 2 (Titration to fixed dose-14 weeks)</content>
<footnote id="id-54f3e866-7c86-4358-825d-9b53ab188fe7">Study in hypertensives with BPH.</footnote>
</td>
</tr>
<tr id="id_bfc0d1f5-196c-4c48-94da-973180ccbae4">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Placebo</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">37</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">20.7</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-2.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">30</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">10.6</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+0.1</td>
</tr>
<tr id="id_f671d99c-4f3d-47fd-9f5e-d8ee13b0962f">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate 4 mg</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">38</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">21.2</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-5.0<footnoteref idref="id-eeda9e0c-6df2-45ba-aeb9-76a78be55437"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">32</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.8</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+2.3<footnote id="id-6053ea04-1943-44ed-97d7-5edb5788c893">p &lt; 0.05 compared to placebo mean change.</footnote>
</td>
</tr>
<tr id="id_624d4750-5e22-4819-8775-77a341effd3a">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate 8 mg</td>
<td align="center" stylecode="Rrule" valign="middle">42</td>
<td align="center" stylecode="Rrule" valign="middle">19.9</td>
<td align="center" stylecode="Rrule" valign="middle">-4.2<footnoteref idref="id-6053ea04-1943-44ed-97d7-5edb5788c893"></footnoteref>
</td>
<td align="center" stylecode="Rrule" valign="middle">36</td>
<td align="center" stylecode="Rrule" valign="middle">10.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+3.3<footnoteref idref="id-eeda9e0c-6df2-45ba-aeb9-76a78be55437"></footnoteref>
</td>
</tr>
</tbody>
</table>